Ivabradine Versus Amiodarone in the Management of Postoperative Junctional Ectopic Tachycardia: A Randomized,

Balaji Arvind1, Shyam S Kothari1, Rajnish Juneja1

  • 1Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.

Insights

Ivabradine is as effective as amiodarone for treating junctional ectopic tachycardia (JET) after pediatric cardiac surgery. Both drugs restored sinus rhythm similarly, though amiodarone offered faster rate control without adverse events in the ivabradine group.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Electrophysiology
  • Pharmacology

Background:

  • Junctional ectopic tachycardia (JET) is a significant postsurgical complication in children undergoing cardiac procedures.
  • Amiodarone is the traditional treatment, but ivabradine has emerged as a potential alternative.
  • Effective management of JET is crucial for improving patient outcomes post-cardiac surgery.

Purpose of the Study:

  • To compare the efficacy of ivabradine versus amiodarone in managing postoperative JET in pediatric patients.
  • To evaluate the primary endpoint of sinus rhythm restoration and secondary endpoints including time to conversion and rate control.
  • To assess the safety profile of both pharmacological interventions.

Main Methods:

  • An open-label randomized controlled trial involving 94 pediatric patients (age ≤18 years) with postoperative JET.
  • Patients were randomized to receive either intravenous amiodarone or oral ivabradine.
  • The primary outcome was the restoration of normal sinus rhythm, with secondary outcomes including time to rhythm conversion and rate control.

Main Results:

  • Both amiodarone (93.5%) and ivabradine (95.8%) demonstrated high efficacy in converting JET to sinus rhythm, showing non-inferiority.
  • The median time to achieve sinus rhythm was comparable between the amiodarone and ivabradine groups (21.5 vs. 22 hours).
  • Amiodarone showed a significantly faster time to JET rate control (7.0 vs. 8.0 hours), with no adverse events reported for ivabradine.

Conclusions:

  • Oral ivabradine is a non-inferior alternative to intravenous amiodarone for converting postoperative JET to sinus rhythm in children.
  • While rhythm conversion times were similar, amiodarone provided earlier rate control.
  • Ivabradine monotherapy presents a viable alternative to amiodarone for managing pediatric postoperative JET, particularly given its favorable safety profile.
Abstract

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.5K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.1K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.2K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
203
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.2K
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
283